Geenius HCV Supplemental Controls - Hepatitis C virus total antibody IVD, control

Access comprehensive regulatory information for Geenius HCV Supplemental Controls - Hepatitis C virus total antibody IVD, control in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Bio-Rad Laboratories Pty Ltd, manufactured by Bio-Rad in France. The device registration started on October 28, 2020.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.